SASajeda Akter

Sajeda Akter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sajeda Akter has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 3 March 2026
      • Vol. 2026, 9813151
    Open Access

    Pharmacological and Computational Insights Into the Analgesic, Antipyretic, and Antidiarrheal Potential of Mallotus paniculatus Acetone Extract.

    by Jahirul Islam Mamun, Abdul Alim, Sadia Tamanna Tamim, Iqbal Hossen, Sajib Chandro Das, Tanbirul Azim Maharaj, Dipta Debnath, Sajeda Akter, S M Moazzem Hossen

    Mallotus paniculatus (Lam.), a member of the Euphorbiaceae Juss family, is a little tree or shrub that has long been used in folk medicine to cure ailments like fever, wound healing, and postpartum recuperation. In this study, Swiss albino mice were used to evaluate the analgesic, antipyretic, and antidiarrheal properties of the acetone extract of M. paniculatus (AMP). Standard screening techniques were used to identify the phytochemical ingredients. Three models were used to evaluate analgesic activity: the tail immersion test, formalin-induced paw licking, and acetic acid-induced writhing. Antipyretic activity was assessed using a fever model induced by brewer's yeast. At the same time, antidiarrheal effects were evaluated by castor oil-induced diarrhea, and gastrointestinal motility was studied using a charcoal meal marker. Furthermore, in silico analyses-such as molecular docking, ADME profiling, toxicity prediction, and PASS analysis-were conducted using online tools. The results indicated that AMP at a lower dose (200 mg/kg) produced significant analgesic effects across all pain models compared with the control group. In the antipyretic evaluation, AMP administered at 400 mg/kg illustrated the most pronounced reduction in body temperature after 4 h, which was statistically significant (p < 0.01). The same higher dose (400 mg/kg) also significantly reduced diarrheal episodes and slowed gastrointestinal motility in both the castor oil-induced diarrhea and charcoal meal transit tests. Molecular docking analysis further corroborated these pharmacological effects, revealing that AMP compounds exhibited strong binding affinity toward key target receptors associated with pain, inflammation, and gastrointestinal activity. Collectively, these results indicate that AMP has promising potential as a natural multitarget therapeutic agent for the treatment of pain, fever, and diarrhea.


  • Open Access

    Protective Effects of Mussaenda pubescens Leaf Extracts Against Oxidative Stress and Dyslipidemia

    by Md. Tazim Hasan Fahim, Ummah Tasnim Nisat, Nazratun Noor Maria, Nusrat Jahan, Sajeda Akter, Aftab A. Sorwar

    Objective: Mussaenda pubescens (Rubiaceae) is a medicinal plant, traditionally utilized for gastrointestinal, febrile, and reproductive ailments. This study was aimed at analyzing the antioxidant capacity and antihyperlipidemic efficacy of the methanolic extract of M. pubescens in a high‐cholesterol diet‐induced hyperlipidemic mouse model. Methods: Twenty‐five Swiss albino mice were randomly subdivided into five groups of five mice each: normal control, disease control, atorvastatin (20 mg/kg), 200 mg/kg of the extract, and 400 mg/kg of the extract. Hyperlipidemia was achieved by feeding a high‐fat diet for 28 days before the oral treatment was given for 12 consecutive days. The serum lipid profile and DPPH radical scavenging activity were then analyzed. Results: The extract improved the lipid abnormalities when compared with untreated hyperlipidemic mice ( p < 0.05). At 200 mg/kg, LDL‐C decreased to 11.25 ± 1.05 mg/dL, whereas the 400 mg/kg dose reduced TG and VLDL‐C to 140.50 ± 6.50 and 28.10 ± 1.30 mg/dL, respectively. Atorvastatin demonstrated greater lipid normalization. The antioxidant activity was also shown by the extract with a DPPH assay, with an IC 50 value of 235.64 μ g/mL. Conclusion: The methanolic extract of M. pubescens exhibits potent antihyperlipidemic and antioxidant activities, validating its potential as a promising phytotherapeutic candidate for the management of hyperlipidemia and oxidative stress–associated metabolic disorders. Further in‐depth phytochemical profiling and mechanistic studies are required for better evaluation of this extract.

  • Open Access

    Pharmacological Investigation of Syzygium diospyrifolium Fruit Extract: Antimicrobial and Diuretic Evidence From Experimental, DFT and Molecular Docking Studies

    by Jahirul Islam Mamun, Sajeda Akter, Zobayed Islam, Iqbal Hossen, Hossain Rasel, Nazmul Hasan Eshaque, Qurratul Ain Sadia, Mahmudul Hasan

    Syzygium diospyrifolium , a member of the family Myrtaceae, is traditionally used in South and Southeast Asia for the management of infectious and systemic disorders; however, its pharmacological validation remains limited. This study evaluated the antimicrobial and diuretic activities of the methanolic extract of S . diospyrifolium (MESD) fruits using in vitro, in vivo and in silico approaches to substantiate its ethnomedicinal relevance. Antibacterial activity was assessed by the disc diffusion method against selected Gram‐positive and Gram‐negative bacterial strains, while diuretic activity was examined in albino mice by measuring urine volume, electrolyte (Na + , K + and Cl − ) excretion, diuretic index and Lipschitz values, with furosemide serving as the standard reference drug. MESD demonstrated notable antibacterial activity against both bacterial groups, with pronounced inhibition against Pseudomonas aeruginosa and Bacillus megaterium , showing activity comparable to or exceeding that of amoxicillin at the tested concentration. In vivo evaluation revealed a significant, dose‐dependent diuretic effect, characterised by increased urine output and enhanced electrolyte excretion, particularly at a dose of 400 mg/kg, which produced a diuretic index close to that of furosemide. To explore possible mechanisms of action, identified phytoconstituents were subjected to molecular docking against antibacterial (1HTB and 1LX6) and diuretic‐related (1Z9Y and 7S1Y) protein targets using PyRx and CB‐Dock. Friedelan‐3‐one and β‐sitosterol exhibited strong binding affinities comparable to or greater than those of standard drugs. Additionally, ADME/T, toxicity prediction, PASS analysis, density functional theory (DFT) and molecular electrostatic potential studies supported the favourable pharmacokinetic profiles, chemical reactivity and interaction potential of the major compounds. Overall, the findings highlight S. diospyrifolium as a promising natural source of antimicrobial and diuretic agents, warranting further investigation.


  • Open Access

    Antianemic Potential of Artocarpus chaplasha Seeds in Phenyl Hydrazine–Induced Hemolytic Anemia: Evidence From Swiss Albino Mice and Molecular Docking Studies

    by Nazratun Noor Maria, Ummah Tasnim Nisat, Nusrat Jahan, Zobayed Islam, Adnan Shahriar Chowdhury, Mehnaz Sarwar, Sajeda Akter

    Background and Aim: Anemia affects billions, primarily young women and men. Taking steroids and immunosuppressants might cause side effects. So recent studies are focusing on natural hematinic agents to cure anemia. This study examined Artocarpus chaplasha seeds against phenyl hydrazine–induced hemolytic anemia in Swiss albino mice. Methods: To induce anemia, mice administered 60 mg/kg phenyl hydrazine intraperitoneally for 2 days. On Day 3, decreased RBC, hemoglobin, and hematocrit levels revealed anemia. Mice were orally treated with A. chaplasha seed methanol extract. Vitamin B 12 was the reference standard. Post 200 and 400 mg/kg test extract administration, blood was taken for hematological analysis on Day 15. All in vivo results were analyzed and supported through in silico approach. Results: Compared to positive control group, A. chaplasha seeds doses of 200 and 400 mg/kg significantly ( ∗∗ p < 0.01) increased RBC levels. Hemoglobin levels considerably increased with 200 mg/kg ( ∗ p < 0.05) and 400 mg/kg ( ∗∗ p < 0.01). The 200 and 400 mg/kg doses significantly elevated hematocrit (PCV) levels ( ∗ p < 0.05 and ∗∗∗ p < 0.001). Furthermore, in silico molecular docking studies showed significant binding affinity of the compounds against the receptor protein (PDB ID: 2HHB). With −7.2 kcal/mol, neophytadiene bound strongly. Conclusion: The in vivo activity demonstrate increase in the RBC level, and docking score shows comparability to the positive control, folinic acid with a score of −6.9 kcal/mol. Thus, the A. chaplasha seed may be a promising natural anemic treatment.

  • Top Cited Papers
    Open Access

    Pharmacological and Computational Insights Into the Analgesic, Antipyretic, and Antidiarrheal Potential of Mallotus paniculatus Acetone Extract

    by Jahirul Islam Mamun, Abdul Alim, Sadia Tamanna Tamim, Iqbal Hossen, Sajib Chandro Das, Tanbirul Azim Maharaj, Dipta Debnath, Sajeda Akter, S. M. Moazzem Hossen

    Mallotus paniculatus (Lam.), a member of the Euphorbiaceae Juss family, is a little tree or shrub that has long been used in folk medicine to cure ailments like fever, wound healing, and postpartum recuperation. In this study, Swiss albino mice were used to evaluate the analgesic, antipyretic, and antidiarrheal properties of the acetone extract of M. paniculatus (AMP). Standard screening techniques were used to identify the phytochemical ingredients. Three models were used to evaluate analgesic activity: the tail immersion test, formalin‐induced paw licking, and acetic acid–induced writhing. Antipyretic activity was assessed using a fever model induced by brewer′s yeast. At the same time, antidiarrheal effects were evaluated by castor oil–induced diarrhea, and gastrointestinal motility was studied using a charcoal meal marker. Furthermore, in silico analyses—such as molecular docking, ADME profiling, toxicity prediction, and PASS analysis—were conducted using online tools. The results indicated that AMP at a lower dose (200 mg/kg) produced significant analgesic effects across all pain models compared with the control group. In the antipyretic evaluation, AMP administered at 400 mg/kg illustrated the most pronounced reduction in body temperature after 4 h, which was statistically significant ( p < 0.01). The same higher dose (400 mg/kg) also significantly reduced diarrheal episodes and slowed gastrointestinal motility in both the castor oil–induced diarrhea and charcoal meal transit tests. Molecular docking analysis further corroborated these pharmacological effects, revealing that AMP compounds exhibited strong binding affinity toward key target receptors associated with pain, inflammation, and gastrointestinal activity. Collectively, these results indicate that AMP has promising potential as a natural multitarget therapeutic agent for the treatment of pain, fever, and diarrhea.


  • Open Access

    Sweroside in Focus: A Comprehensive Review of Its Sources, Pharmacokinetics, and Pharmacological Actions

    by Liakot Ali, Sajeda Akter, Sadia Hosna Rony, Jahirul Islam Mamun, Hossain Rasel, Mohammed Kamrul Hossain, Nawreen Monir Proma

    Sweroside is a natural iridoid glycoside found abundantly in a diverse range of medicinal plants, many of which are valued for their traditional therapeutic uses. This review offers an in-depth overview of its distribution, pharmacokinetic profile, and pharmacological activities. So far, sweroside has been reported from 46 plant species within 19 genera, belonging to seven plant families—several of which are commonly used in traditional Chinese medicine, where sweroside functions as a key bioactive marker. Pharmacokinetic studies revealed that sweroside is rapidly metabolized in the liver, has a relatively short duration of action, and is primarily eliminated via the kidneys in its metabolite form. A wide range of in vitro and animal studies have shown that sweroside exhibits multiple therapeutic effects, including bone-protective, liver-protective, heart-protective, brain-protective, anti-inflammatory, anti-infective, and dermatological benefits. This review focuses on the latest research exploring its mechanisms of action across various disease-specific signaling pathways. The broad therapeutic range of sweroside further supports its potential as a drug candidate, although improving its pharmacokinetic properties and validating its safety through clinical studies will be critical for future development.